Welcome to our dedicated page for Borgwarner SEC filings (Ticker: BWA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BorgWarner Inc. (NYSE: BWA) SEC filings page provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings offer detail on trading symbols, dividend declarations, financial results, legal matters, and other material events that affect the company and its securities.
In recent 8-K filings, BorgWarner identifies its common stock, par value $0.01 per share, trading under the symbol BWA on the New York Stock Exchange, and its 1.00% Senior Notes due 2031 trading under the symbol BWA31. The company uses Form 8-K to furnish earnings press releases for its quarterly and year-to-date results, outlining net sales, operating margin, earnings per share, and the impact of non-comparable items. These filings also reference updated guidance ranges for net sales, margins, and cash flow.
Other 8-K items describe Board-approved quarterly cash dividends on BorgWarner’s common stock, specifying per-share amounts, record dates, and payment dates. Filings also address legal and structural matters, such as the settlement with PHINIA Inc. related to value added tax refunds and issues connected to a prior spin-off that created PHINIA as an independent company. In these disclosures, BorgWarner explains how related charges are treated as non-comparable items for earnings presentation.
On Stock Titan, users can review BorgWarner’s SEC filings with AI-powered summaries that help explain the key points of lengthy documents. This includes highlighting the main elements of 10-K annual reports, 10-Q quarterly reports, and 8-K current reports, as well as drawing attention to dividend declarations, guidance updates, and significant legal or transactional disclosures. The filings are updated as they are made available on EDGAR, allowing investors to monitor BorgWarner’s regulatory reporting and capital markets activity in one place.
BorgWarner reported a Form 144 notice disclosing a proposed sale of 5,000 shares of its common stock with an aggregate market value of $202,500 and an approximate sale date of 08/13/2025. The shares were acquired on 02/28/2022 through the vesting of restricted stock units granted under the issuer's equity compensation plan. The filing lists 216,392,876 shares outstanding and identifies Merrill Lynch as the broker. The filing also reports prior sales by the same person of 20,000 shares on 08/04/2025 for $763,383.17 and 15,000 shares on 08/12/2025 for $589,718.34. The signer certifies they are unaware of undisclosed material adverse information.
Rule 144 notice to sell 15,000 shares of BorgWarner common stock is reported to be executed through Merrill Lynch with an aggregate market value of $589,718.34 and an approximate sale date of 08/12/2025. The filing reports 216,392,876 shares outstanding, so the block to be sold is a very small portion of total shares.
The securities were acquired under the issuer equity compensation plan via vesting of restricted stock units: 10,000 shares vested on 02/08/2019 and 5,000 shares vested on 02/06/2021. The filing also discloses that Stefan Demmerle sold 20,000 shares on 08/04/2025 for gross proceeds of $763,383.17.
The filer affirms, by signing the notice, that they do not know of any material adverse nonpublic information about the issuer not publicly disclosed.
BorgWarner filed a Form 144 reporting a proposed sale of 2,500 common shares to be executed through Charles Schwab on 08/12/2025 with an aggregate market value of $100,025, to be listed on the NYSE. The 2,500 shares equal approximately 0.001155% of the issuer's 216,392,876 shares outstanding, indicating the sale is immaterial to the company’s overall capitalization. The shares were acquired as equity compensation: 1,380 from a restricted stock lapse on 02/28/2020 and 1,120 from a performance stock lapse on 02/05/2025, which together match the 2,500 shares proposed for sale. The filing also discloses two prior dispositions in the past three months totaling 10,000 shares for aggregate proceeds of $354,800. The signer represents no known undisclosed material adverse information.
BorgWarner's Schedule 13G/A shows Victory Capital Management, Inc. beneficially owns 7,798,478 shares of common stock, equal to 3.55% of the class. Victory Capital reports sole voting power over 7,588,779 shares and sole dispositive power over 7,798,478 shares, and classifies itself as an investment adviser (IA). The filing includes a certification that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Reporting person: Isabelle McKenzie (Vice President, officer).
Transaction: On 08/04/2025 Ms. McKenzie sold 5,000 shares of BorgWarner Inc. (BWA) common stock at $37.71 per share.
Holdings after transaction: 58,445 shares. The Form 4 was filed and signed by Miyuki P. Oshima as attorney-in-fact on 08/06/2025.